HTLV-1 Tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration

被引:104
作者
Ariumi, Y
Kaida, A
Lin, JY
Hirota, M
Masui, O
Yamaoka, S
Taya, Y
Shimotohno, K [1 ]
机构
[1] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan
[2] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138519, Japan
[3] Natl Canc Ctr, Res Inst, Chuo Ku, Tokyo 1040045, Japan
关键词
p53; Tax; HTLV-1; CBP; CREB; NF-kappa B;
D O I
10.1038/sj.onc.1203450
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein repressed the transcriptional activity of wildtype p53 through its N-terminal trans-activation domain, Although Tax did not directly bind to p53, this repression required the activation of CREB pathway by Tax, In contrast to a recent report by Pise-Masison et al, (1998a,b) we found that the phosphorylation of p53 on Ser 15 is not a major cause of the Tax-mediated inactivation of p53, However, Tax with a mutation in the coactivator CBP-binding site (K88A), which activates NF-kappa B but not the CREB pathway, could not repress the p53 trans-activation function, Moreover, Tax inhibited p53 binding to CBP in vitro and inhibited synergistic activation of transcription by CBP and p53, Thus, Tax is likely to compete with p53 in binding with CBP, thereby repressing its trans-activation function.
引用
收藏
页码:1491 / 1499
页数:9
相关论文
共 55 条
[1]   Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1 [J].
Akagi, T ;
Ono, H ;
Tsuchida, N ;
Shimotohno, K .
FEBS LETTERS, 1997, 406 (03) :263-266
[2]   Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes [J].
Akagi, T ;
Ono, H ;
Nyunoya, H ;
Shimotohno, K .
ONCOGENE, 1997, 14 (17) :2071-2078
[3]  
Akagi T, 1996, ONCOGENE, V12, P1645
[4]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[5]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[6]   SITE-SPECIFIC BINDING OF WILD-TYPE-P53 TO CELLULAR DNA IS INHIBITED BY SV40-T ANTIGEN AND MUTANT P53 [J].
BARGONETTI, J ;
REYNISDOTTIR, I ;
FRIEDMAN, PN ;
PRIVES, C .
GENES & DEVELOPMENT, 1992, 6 (10) :1886-1898
[7]   P53 functional impairment and high p21(waf1/cip1) expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells [J].
Cereseto, A ;
Diella, F ;
Mulloy, JC ;
Cara, A ;
Michieli, P ;
Grassmann, R ;
Franchini, G ;
Klotman, ME .
BLOOD, 1996, 88 (05) :1551-1560
[8]   TRANSACTIVATION ABILITY OF P53 TRANSCRIPTIONAL ACTIVATION DOMAIN IS DIRECTLY RELATED TO THE BINDING-AFFINITY TO TATA-BINDING PROTEIN [J].
CHANG, J ;
KIM, DH ;
LEE, SW ;
CHOI, KY ;
SUNG, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :25014-25019
[9]  
Chen JD, 1996, MOL CELL BIOL, V16, P2445
[10]   Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor [J].
Dobner, T ;
Horikoshi, N ;
Rubenwolf, S ;
Shenk, T .
SCIENCE, 1996, 272 (5267) :1470-1473